Switch to
More onapp

Dishman Carbogen Amcis Ltd

DCAL
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹1,293 cr, stock is ranked 952
Moderate RiskStock is 2.82x as volatile as Nifty
83.050.55 (+0.67%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹1,293 cr, stock is ranked 952
Moderate RiskStock is 2.82x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
71.82
PB RatioPB Ratio
0.23
Dividend YieldDiv. Yield
Sector PESector PE
33.80
Sector PBSector PB
4.14
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Dishman Carbogen Amicis Limited is an India-based contract research and manufacturing services (CRAMS) company. The Company is engaged in the process of research and development to late-stage clinical and commercial manufacturing

Investor PresentationView older 

Nov 11, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

20192020202120222.112.091.952.180.210.16-0.170.02
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Board Meeting Intimation 
Announced OnFeb 3, 2023

DISHMAN CARBOGEN AMCIS LIMITEDhas informed the Exchange about Board Meeting to be held on 10-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 . | Download

DISHMAN CARBOGEN AMCIS LIMITEDhas informed the Exchange about Board Meeting to be held on 10-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 . | Download

Press Release 
Announced OnFeb 1, 2023

Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated February 01, 2023, titled "Announcement: Company s wholly-owned subsidiary viz. CARBOGEN AMCIS SAS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France". | Download

Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated February 01, 2023, titled "Announcement: Company s wholly-owned subsidiary viz. CARBOGEN AMCIS SAS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France". | Download

Cash Dividend 
Ex. DateSep 12, 2019

Final • Div/Share: ₹ 0.2

See all events